First Patient Dosed With Drug Combo in Phase 2 Gastric Cancer Trial
A patient in a phase 2 trial has received the first dose of a novel combination of botensilimab and balstilimab plus agenT-979, an allogeneic cell therapy.
Source: curetoday.com
Vitrakvi Continues News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Vitrakvi Continues. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Vitrakvi Continues Today - Breaking & Trending Today